Gsk

British drug firm claims its antibody vaccine works against Omicron

GlaxoSmithKline hopes to complete testing by year's end to confirm whether the drug is effective against all the various mutations seen with the variant.

Sharing patents alone won't solve global vaccine shortage, say experts

Patents are just one part of the vaccine puzzle. The key is the know-how about the actual manufacturing process.

Are Chinese and Russian Covid-19 vaccines victims of prejudice?

Delays in sharing clinical trial data is one of the key reasons behind skepticism.

Vaccines boost Big Pharma’s image, but won’t change its ways

The development of Covid-19 vaccines in record time will not be enough to fix big pharma’s tarnished image.

Sanofi-GSK delays its Covid-19 vaccine launch over low immune response

The two companies said they planned to launch another study next year, hoping to come up with a more effective vaccine by the end of 2021.

Search for a Covid-19 vaccine heats up in China and US

Initial vaccine tests focus on safety, and researchers in both countries are trying out different doses of different types of shots. Second phase allows vaccines to be tested to look for signs that they protect against infection.

GSK and Pfizer to merge consumer health care units

GSK said it would have a 68-percent controlling equity interest in the joint venture that will have combined sales of about $13 billion.

Ghana, Kenya and Malawi to pilot GSK malaria vaccine

British drugmaker GlaxoSmithKline developed the injectable vaccine to protect children from the most deadly form of malaria in Africa.